Inflammation and immune system activation in aging: A mathematical approach

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Nikas, Jason B ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; AREA UNDER THE CURVE; CLUSTER ANALYSIS; FACTUAL DATABASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HIPPOCAMPUS; HUMAN; IMMUNE SYSTEM; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; THEORETICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AGING; AREA UNDER CURVE; CLUSTER ANALYSIS; DATABASES, FACTUAL; FEMALE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MALE; MIDDLE AGED; MODELS, THEORETICAL; ROC CURVE;

EID: 84888188543     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep03254     Document Type: Article

References (47)

1. Morrison, J. H. & Baxter, M. G. The ageing cortical synapse: hallmarks and implications for cognitive decline. Nat. Rev. Neurosci. 13, 240-250 (2012).
2. Bishop, N. A., Lu, T. & Yankner, B. A. Neural mechanisms of ageing and cognitive decline. Nature 464, 529-535 (2010).
3. Pakkenberg, B. et al. Aging and the human neocortex. Exp. Gerontol. 38, 95-99 (2003). (Pubitemid 36110503)
4. Benoit, C. E., Rowe, W. B., Menard, C., Sarret, P. & Quirion, R. Genomic and proteomic strategies to identify novel targets potentially involved in learning and memory. Trends Pharmacol. Sci. 32, 43-52 (2011).
5. Berchtold, N. C. et al.Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc. Natl. Acad. Sci. USA 105, 15605-15610 (2008).
6. Nikas, J. B., Boylan, K. L., Skubitz, A. P. & Low, W. C. Mathematical prognostic biomarker models for treatment response and survival in epithelial ovarian cancer. Cancer Inform. 10, 233-247 (2011).
7. Nikas, J. B., Low, W. C. & Burgio, P. A. Prognosis of treatment response (pathological complete response) in breast cancer. Biomark. Insights 7, 59-70 (2012).
8. Hodges, A. et al. Regional and cellular gene expression changes in human Huntington's disease brain. Hum. Mol. Genet. 15, 965-977 (2006). (Pubitemid 43338237)
9. Rogers, J. et al. Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 89, 10016-10020 (1992).
10. Fujikado, N., Saijo, S. & Iwakura, Y. Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis. Arthritis Res. Ther. 8, R100 (2006).
11. Xu, K., Bastia, E. & Schwarzschild, M. Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease. Pharmacol. Ther. 105, 267-310 (2005). (Pubitemid 40297894)
12. Trincavelli, M. L. et al. A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation. Mol. Pharmacol. 62, 1373-1384 (2002). (Pubitemid 35403832)
13. Strand, A. D. et al. Gene expression in Huntington's disease skeletal muscle: a potential biomarker. Hum. Mol. Genet. 14, 1863-1876 (2005). (Pubitemid 41418057)
14. Sharp, F. R. et al. The future of genomic profiling of neurological diseases using blood. Arch. Neurol. 63, 1529-1536 (2006). (Pubitemid 44748794)
15. Rangel-Moreno, J. et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J. Clin. Invest. 116, 3183-3194 (2006). (Pubitemid 44878632)
16. Pileri, S. A. et al. Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins. Am. J. Pathol. 162, 243-253 (2003). (Pubitemid 36042006)
17. Li, Y. et al. Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J. Immunol. 178, 1938-1947 (2007). (Pubitemid 46154667)
18. Jemas, M., Nookaew, I., Wadenvik, H. & Olsson, B. MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP) Blood 121, 2095-2098 (2013).
19. Sherman, L. et al. CD44 expression is aberrant in benign Schwann cell tumors possessing mutations in the neurofibromatosis type 2, but not type 1, gene. Cancer Res. 57, 4889-4897 (1997). (Pubitemid 27468999)
20. Reghunathan, R. et al. Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol. 6, 2
21. Kohl, J. & Wills-Karp, M. Complement regulates inhalation tolerance at the dendritic cell/T cell interface. Mol. Immunol. 44, 44-56 (2007). (Pubitemid 44647103)
22. Baranzini, S. E. et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis. Nature 464, 1351-1356 (2010).
23. Davidson, A. & Diamond, B. Autoimmune diseases. N. Engl. J. Med. 345, 340-350 (2001).
24. Nogutsi, S. et al. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum. Mol. Genet. 12, 595-600 (2003).
25. Terao, A. et al. Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol. 132, 99-112 (2002). (Pubitemid 35333331)
26. Weindruch, R., Kayo, T., Lee, C. K. & Prolla, T. A. Gene expression profiling of aging using DNA microarrays. Mech. Ageing Dev. 123, 177-193 (2002). (Pubitemid 33097564)
27. Chapman, T. R., Barrientos, R. M., Ahrendsen, J. T., Maier, S. F. & Patterson, S. L. Synaptic correlates of increased cognitive vulnerability with aging: peripheral immune challenge and aging interact to disrupt theta-burst late-phase long-term potentiation in hippocampal area CA1. J. Neurosci. 30, 7598-7603 (2010).
28. Lynch, M. A. Age-related neuroinflammatory changes negatively impact on neuronal function. Front. Aging Neurosci. 1(6), (2010).
29. Rao, J. S., Kellom, M., Kim, H. W. & Rapoport, S. I. Neuroinflammation and synaptic loss. Neurochem. Res. 37, 903-910 (2012).
30. Smith, T. D., Adams, M. M., Gallagher, M.,Morrison, J. H. & Rapp, P. R. Circuitspecific alterations in hippocampal synaptophysin immunoreactivity predict spatial learning impairment in aged rats. J. Neurosci. 20, 6587-6593 (2000).
31. Lu, T. et al. Gene regulation and DNA damage in the ageing human brain. Nature 429, 883-891 (2004). (Pubitemid 38843301)
32. Lee, C. K., Weindruch, R. & Prolla, T. A. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25, 294-297 (2000). (Pubitemid 30437315)
33. Rapp, P. R.& Gallagher, M. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. Proc. Natl. Acad. Sci.USA 93, 9926-9930 (1996). (Pubitemid 26296711)
34. Geinisman, Y. et al. Aging, spatial learning, and total synapse number in the rat CA1 stratum radiatum. Neurobiol. Aging 25, 407-416 (2004). (Pubitemid 38220975)
35. Vlad, S. C., Miller, D. R., Kowall, N. W. & Felson, D. T. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology 70, 1672-1677 (2008). (Pubitemid 351644133)
36. Arvanitakis, Z. et al. Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology. Neurology 70, 2219-2225 (2008).
37. Jonsson, T. et al.Variant of TREM2 associated with the risk of Alzheimer's disease. N. Engl. J. Med. 368, 107-116 (2013).
38. Nikas, J. B., Keene, C. D. & Low, W. C. Comparison of analytical mathematical approaches for identifying key nuclear magnetic resonance spectroscopy biomarkers in the diagnosis and assessment of clinical change of diseases. J. Comp. Neurol. 518, 4091-4112 (2010).
39. Nikas, J. B. & Low, W. C. ROC-supervised principal component analysis in connection with the diagnosis of diseases. Am. J. Transl. Res. 3, 180-196 (2011).
40. Nikas, J. B. & Low, W. C. Application of clustering analyses to the diagnosis of Huntington disease in mice and other diseases with well-defined group boundaries. Comput. Methods Programs Biomed. 104, e133-e147 (2011).
41. Nikas, J. B. & Low,W. C. Linear Discriminant Functions in Connection with the micro-RNA Diagnosis of Colon Cancer. Cancer Inform. 11, 1-14 (2012).
42. Burns, M. B. et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366-370 (2013).
43. Perneger, T. V. What's wrong with Bonferroni adjustments. BMJ 316, 1236-1238 (1998). (Pubitemid 28171344)
44. Feise, R. J. Do multiple outcomemeasures require p-value adjustment? BMC Med. Res. Methodol. 2, 8 (2002).
45. Efron, B. & Tibshirani, R. An Introduction to the Bootstrap. London: Chapman and Hall (1993).
46. Amari, S., Murata, N., Muller, K.-R., Finke, M. & Yang, H. H. Asymptotic Statistical Theory of Overtraining and Cross-Validation. IEEE Trans. Neural Networks 8, 985-996 (1997). (Pubitemid 127763330)
47. Hastie, T., Tibshirani, R. & Friedman, J. The Elements of Statistical Learning. New York: Springer (2001).